IOWA ONCOLOGY RESEARCH ASSOCIATION
[ Home ] [ Treatment ] [ Control & Prevention ] [ STAR ] [ SELECT ] [ Physicians ] [ Contact Us ] [ Helpful Links ]

Genitourinary Cancer Research Studies

ADJUVANT RENAL CELL
E2805   ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma

BLADDER
R0524   A Phase I / II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer

PROSTATE
E3805   CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer

PR.11    A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favorable Risk Prostate Cancer (START)

R0534   Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer patients with a Rising PSA After Radical Prostatectomy

R0815   A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

ADVANCED / METASTATIC RENAL CELL
E2804   The BeST Trial: A Randomized Phase II Study of VEGF, RAF kinase, and mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib and Temsirolimus in Advanced Renal Cell Carcinoma

E4805   Phase II Study to Determine the Effect of 2 Different Doses of VEGF Trap in Metastatic Renal Cell Carcinoma

ADVANCED TRANSITIONAL CELL
C90601   A Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

CANCER CONTROL
C70604   A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer

R0517   Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer

WFU-97405   Randomized Study of Soy Protein and Effexor™ on Vasomotor Symptoms of Men with Prostate Cancer (temporarily suspended)